Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Our group through specialist training. Skilled expert knowledge, sturdy sense of assistance, to fulfill the provider needs of shoppers for 4-Guanidinobenzoic Acid HCl, L-Arg, Boc-L-Homophenylalanine, Our professional technological team will be wholeheartedly at your services. We sincerely welcome you to definitely take a look at our website and enterprise and send out us your inquiry.

Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu Detail:

Commercial Supply Molnupiravir and Related Intermediates with High Quality
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4

Chemical Name	Molnupiravir N-1
Synonyms	((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate; Molnupiravir Intermediate; Molnupiravir Dimethyl Dioxol Impurity; Molnupiravir Impurity 11
CAS Number	2346620-55-9
CAT Number	RF-PI310
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C16H23N3O7
Molecular Weight	369.37
Solubility	Soluble in DMSO
Density	1.51±0.1 g/cm3
Shipping Temperature	Ambient
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Loss on Drying	≤1.0%
Residue on Ignition	≤0.20%
Single Impurity	≤0.50%
Total Impurities	≤2.0%
Heavy Metals	≤20ppm
Purity	≥98.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Molnupiravir (CAS 2349386-89-4) COVID-19

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Molnupiravir N-1 (CAS 2346620-55-9), is the intermediate of Molnupiravir (CAS 2349386-89-4) in treatment of COVID-19. Molnupiravir (EIDD-2801) is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 (7 mg/kg; p.o.; twice daily for 3.5 days) significantly reduces shed virus load and duration of fever. Molnupiravir (EIDD-2801) is efficiently hydrolyzed in vivo after absorption, resulting in detection of only free NHC in plasma. EIDD-2801 robustly reduces MERS-CoV infectious titers, viral RNA, and pathogenesis under both prophylactic and early therapeutic conditions. Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19.

Product detail pictures:

Related Product Guide:

The incredibly rich projects administration experiences and a person to 1 service model make the substantial importance of organization communication and our easy understanding of your expectations for Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu , The product will supply to all over the world, such as: Florence, Niger, UK, Since the establishment of our company, we've realized the importance of providing good quality goods and the best before-sales and after-sales services. Most problems between global suppliers and clients are due to poor communication. Culturally, suppliers can be reluctant to question points they do not understand. We break down these barriers to ensure you get what you want to the level you expect, when you want it.